Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Fusion Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Fusion Pharmaceuticals Inc market cap is $1.83B.
What is the 52-week high for Fusion Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Fusion Pharmaceuticals Inc 52 week high is $21.60 as of September 17, 2025.
What is the 52-week low for Fusion Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Fusion Pharmaceuticals Inc 52 week low is $2.31 as of September 17, 2025.
What is Fusion Pharmaceuticals Inc stock price today?
Fusion Pharmaceuticals Inc stock price today is $21.55.
What was Fusion Pharmaceuticals Inc stock price yesterday?
Fusion Pharmaceuticals Inc stock price yesterday was $21.52.
What is the PE ratio of Fusion Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Fusion Pharmaceuticals Inc’s P/E ratio is -15.21.
What is the Price-to-Book ratio of Fusion Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Fusion Pharmaceuticals Inc P/B ratio is 7.5625.
What is the 50-day moving average of Fusion Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Fusion Pharmaceuticals Inc 50-day moving average is $21.44.
